期刊文献+

人截断型转化生长因子β受体Ⅱ真核表达载体的构建和表达

Construction and Expression of the Eukaryotic Expression Vector Containing Truncated TypeⅡ Human Transforming Growth Factor-beta Receptor
暂未订购
导出
摘要 目的构建无细胞内段基因的人转化生长因子βⅡ型受体(△TβRⅡ)的真核表达载体pEGFP/△TβRⅡ,转染L02细胞以表达融合蛋白EGFP/△TβRⅡ,并检测其生物学活性。方法以质粒H2-3FF为模板,用PCR方法扩增得到人转化生长因子βⅡ型受体(TpRⅡ)胞外段和跨膜段的cDNA,将该cDNA克隆到真核表达载体pEGFP-N2上,构建成pEGFP/△TβRⅡ重组质粒。经双酶切和核酸测序鉴定,将该重组质粒转染L02细胞,用倒置荧光显微镜观察融合蛋白EGFP的表达,并检测其生物学活性。结果L02细胞转染pEGFP/△TβRⅡ重组质粒后,在荧光显微镜下可以观察到融合蛋白EGFP的表达,所表达的蛋白能显著减轻TGF-β1对L02细胞G1~S期的阻滞作用。结论成功构建了pEGFP/△TβRⅡ重组质粒,并表达了有活性的融合蛋白EGFP/△TβRⅡ,为进一步探讨其生物学效应奠定了基础。 Objective To construct a eukaryotic expression vector pEGFP/△TβRⅡ that lacks the cytoplasmic domain of the cDNA of the human transforming growth factor-beta type Ⅱ receptor (△TβRⅡ ), to express the fusion protein EGFP/△TβRⅡ in human embryonic hepatic cell line L02 and to determine its biological activity. Methods The cDNA of type Ⅱ truncated receptor (△TβRⅡ ) that lacks the cytoplasmic domain was amplified by PCR from the plasmid H2-3FF, and the eukaryotic expression plasmid pEGFP/△TβRⅡ was constructed by inserting the △TβRⅡ cDNA into the vector pEGFP-N2. The construction was introduced by transfection into L02 cells after the DNA sequence was confirmed by double digestion and sequencing. The fusion protein EGFP was confirmed by inverted fluorescence microscope and its biological function was determined. Results The specific protein was observed by inverted fluorescence microscope, and the protein significantly attenuated the inhibitory effect of TGFβ1 on L02 cells. Conclusion The eukaryotic expression plasmid pEGFP/△TβRⅡ was successfully constructed and the EGFP/△TβRⅡ fusion protein with biological activity obtained.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2007年第1期130-133,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 湖北省自然科学基金资助项目(No.2004AA301C44)
关键词 人转化生长因子β 受体 转染 重组 transforming growth factor-beta receptors transfection reconstruction
  • 相关文献

参考文献9

  • 1CHIN D,BOYLE G M,PARSONS P G,et al.What is transforming growth factor-beta (TGF-beta)?[J].Br J Plast Surg,2004,57(3):215-221.
  • 2SCHNUR J,OLAH J,SZEPESI A,et al.Thioacetamide-induced hepatic fibrosis in transforming growth factor beta-1 transgenic mice[J].Eur J Gastroenterol Hepatol,2004,16(2):127-133.
  • 3UEBERHAM E,LOW R,UEBERHAM U,et al.Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis[J].Hepatology,2003,37(5):1067-1078.
  • 4YANG Y A,DUKHANINA O,TANG B.Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects[J].J Clin Invest,2002,109(12):1607-1615.
  • 5NAKAMURA T,SAKATA R,UENO T,et al.Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine treated rats[J].Hepatology,2000,32(2):247-255.
  • 6BISWAS S,CHYTIL A,WASHINGON K,et al.Transforming growth factor beta receptor type Ⅱ inactivation promotes the establishment and progression of colon cancer[J].Cancer Res,2004,64(14):4687-4692.
  • 7LIN H Y,WANG X F,NG-EAON E,et al.Expression cloning of the TGF-beta type Ⅱ receptor,a functional transmembrane serine/threonine kinase[J].Cell,1992,68(4):775-785.
  • 8MORIUCHI A,HIRONO S,IDO A,et al.Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes[J].Biochem Biophsres Commun,2001,280 (1):368-373.
  • 9NOZATO E,SHIRAISHI M,NISHIMAKI T.Up-regulation of hepatocyte growth factor caused by an over-expression of transforming growth factor beta,in the rat model of fulminant hepatic failure[J].J Surg Res,2003,115(2):226-234.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部